drug · small molecule
patient view →givinostat hydrochloride
Marketedupdated 2mo agoby Italfarmaco SpA🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for duchenne muscular dystrophy and 1 investigational indication.
indications
investigational
Duchenne Muscular Dystrophy
targets
Histone deacetylase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that